Cipher Pharmaceuticals (TSX:CPH) FFO


TSX:CPH Cipher Pharmaceuticals Inc TSX:CPH
100 GF Score
Price C$16.41
GF Value C$17.03
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

TSX:CPH
100GF Score
Cipher Pharmaceuticals Inc TSX:CPH
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cipher Pharmaceuticals (TSX:CPH) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of C$16.41 is trading 3.6% below its estimated GF Value™ of C$17.03. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for TSX:CPH:

  • FFO:
  • GF Value™: C$17.03 vs. price of C$16.41 (3.6% below fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the TSX:CPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cipher Pharmaceuticals Business Description

Other Exchanges CPHRF:USAPHE:Germany
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
100GF Score

Get the complete analysis for TSX:CPH

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$16.41
Price
C$17.03
GF Value